Genetic determinants of the homocysteine level

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Sunder Plassmann, Gere ^a   Födinger, Manuela ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

B12 deficiency; Glutamate carboxypeptidase; Homosysteine; Reduced folate carrier 1; Transcobalamin II

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; REDUCED FOLATE CARRIER; TRANSCOBALAMIN II; CARBOXYPEPTIDASE; CARRIER PROTEIN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE; SLC19A2 PROTEIN, HUMAN; TRANSCOBALAMIN;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; NEURAL TUBE DEFECT; PHARMACOGENETICS; PRIORITY JOURNAL; VITAMIN METABOLISM; BLOOD; GENETICS; REVIEW;

ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CARRIER PROTEINS; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; TRANSCOBALAMINS;

EID: 0037406381     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.52.x     Document Type: Conference Paper

References (22)

1. FÖDINGER M, WAGNER OF, HÖRL WH, SUNDER-PLASSMANN G: Recent insights into the molecular genetics of the homocysteine metabolism. Kidney Int 59, Suppl 78:S238-242, 2001
2. DEVLIN AM, LING E, PEERSON JM, et al: Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 9:2837-2844, 2000
3. CHANGO A, EMERY-FILLON N, DE COURCY GP, et al: A polymorphism (80G>A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:810-815, 2000
4. NAMOUR F, OLIVIER JL, ABDELMOUTTALEB II, et al: Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: Relation to transcobalamin and homocysteine concentration in blood. Blood 97:1092-1098, 2001
5. FÖDINGER M, MANNHALTER C, WÖLFL G, et al: Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52:517-523, 1997
6. VYCHYTIL A, FÖDINGER M, WÖLFL G, et al: Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney Int 53:1775-1782, 1998
7. FÖDINGER M, WÖLFL G, FISCHER G, et al: Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55:1072-1080, 1999
8. 12 plasma concentrations in kidney graft recipients. J Am Soc Nephrol 11:1918-1925, 2000
9. FÖDINGER M, HÖRL WH, SUNDER-PLASSMANN G: Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 13:20-33, 2000
10. UELAND PM, HUSTAD S, SCHNEEDE J, et al: Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195-201, 2001
11. HAUSER AC, HAGEN W, REHAK PH, et al: Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am J Kidney Dis 37:758-765, 2001
12. SUNDER-PLASSMANN G, FÖDINGER M, BUCHMAYER H, et al: Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: Results of the Vienna Multicenter Study. J Am Soc Nephrol 11:1106-1116, 2000
13. SKOUPY S, FÖDINGER M, VEITL M, et al: Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. J Am Soc Nephrol 13:1331-1337, 2002
14. DE MARCO P, CALEVO MG, MORONI A, et al: Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 11(Suppl 1):S14-17, 2001
15. SHAW GM, LAMMER EJ, ZHU H, et al: Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1-6, 2002
16. BRANCACCIO R, PASSARIELLO A, BUONINCONTI A, et al: Multiple genotyping for genes of the folate/methionine metabolism in Italian NTD patients. Homocysteine Metabolism Abstract Book:40, 2001
17. VARGAS-MARTINEZ C, ORDOVAS JM, WILSON PW, SELHUB J: The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring cohort. J Nutr 132:1176-1179, 2002
18. LIEVERS K, KLUIJTMANS L, BOERS G, et al: Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C->T) on plasma homocysteine, folate and vitamin B(12) levels and its relationship to cardiovascular disease risk. Atherosclerosis 164:269-273, 2002
19. McCADDON A, BLENNOW K, HUDSON P, et al: Transcobalamin polymorphism and homocysteine. Blood 98:3497-3499, 2001
20. MILLER JW, RAMOS MI, GARROD MG, et al: Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 100:718-720, 2002
21. AFMAN LA, LIEVERS KJ, VAN DER PUT NM, et al: Single nucleotide polymorphisms in the transcobalamin gene: Relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 10:433-438, 2002
22. LIEVERS KJ, AFMAN LA, KLUIJTMANS LA, et al: Polymorphisms in the transcobalamin gene: Association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem 48:1383-1389, 2002